Vadim Gurvich

COP - Image - Size 3 - COP - Gurvich vadim

Vadim J. Gurvich, Ph.D., M.S., M.B.A.

Academic Title

Research Associate Professor
Medicinal Chemistry/ Institute for Therapeutics Discovery & Development

Associate Director - Institute for Therapeutics Discovery & Development


M.B.A., University of Kansas, 2003 & M.S., Chemical Engineering, Mendeleev University of Chemical Technology, 1987
Ph.D., Organic Chemistry, Hebrew University of Jerusalem, 1996

Contact Info




Office Address

717 Delaware St SE, Room 487

Mailing Address

Institute for Therapeutics Discovery & Development (ITDD)
717 Delaware Street SE
Room 451
Minneapolis, Minnesota 55414

Research Interests

  • Drug discovery
  • Drug synthesis
  • Drug development
  • Synthetic organic and medicinal chemistry


Benyumov, A.; Gurvich, V.J.; Lis, L. G.; Williams, B.W.; Kirstein, M.N. Combinatorial pharmacologic effects for gemcitabine and metabolite dFdU. ChemMedChem 2011, 6, 457-464.

Rangwala, H.S.; Giraldes, J.W.; Gurvich, V.J. Synthesis and purification of [2-13C]-5-Fluorouracil. J. Label. Compd. Radiopharm. 2011, 54(6), 340-3.

Lis L.G.; Smart, M.A.; Luchniak, A.; Gupta, M.L.; Gurvich, V.J. Synthesis and biological evaluation of a biotinylated paclitaxel with an extra-long chain spacer arm. Med. Chem. Lett. 2012, 3, 745-8.

Stenland, C.J.; Lis, L. G.; Schendel, F. J.; Hahn, N. J.; Smart, M.A.; Miller, A.L.; von Keitz, M.G.; Gurvich, V.J. A Practical and Scalable Manufacturing Process for an Antifungal Agent, Nikkomycin Z. Organic Process Research & Development 2013, 17, 265-272.

Gurvich, V.J.; Byrn, S.R. NIPTE: a multi-university partnership supporting academic drug development. Drug Discovery Today 2013, 18, 916-921. 

Khatri, A.; Williams, B.W.; Fisher, J.; Brundage, R.C.; Gurvich, V.J.; Lis, L.G.; Skubitz, K.M.; Dudek, A.Z.; Greeno, E.W.; Kratzke, R.A.; Lamba, J.K.; Kirstein, M.N. SLC28A3 genotype and gemcitabine rate of infusion affect dFdCTP metabolite disposition in patients with solid tumours. Br. J. Cancer 2014, 110, 304-312.

Dosa, P.I.; Georg, G.I.; Gurvich, V.J.; Hawkinson, J.E.; Walters, M.A.; Wong, H.L. From HTS to Phase I: The Institute for Therapeutics Discovery and Development at the University of Minnesota. Comb. Chem. High Throughput Screening 2014, 17, 231-240.


Institute for Therapeutics Discovery & Development (ITDD)

  • ©2014 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on April 16, 2014